CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
Research CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. (600062.SS) on Bullrun: market cap CNY 16.08B, P/E 10.3, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker600062.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCNY
- Market capCNY 16.08B
- P/E10.3
- Dividend yield2.5%
- Financial periodQ2 2026
- RevenueCNY 2.81B
- Net incomeCNY 461.41M
- Free cash flowCNY 312.63M
- Gross margin57.2%
Valuation Snapshot
latest market cap is CNY 16.08B; P/E is 10.3; dividend yield is 2.5%.
Peer valuation comparison
Latest P/E is 10.25x versus a Healthcare sector median of 21.8x (53.0% below).
Latest dividend yield is 2.45% versus a Healthcare sector median of 2.4% (2.1% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 16.08B | 10.3 | 3.1% | 0.48 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.48 CNY, yield 2.5%.
About CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China.
ETFs that hold CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
US-listed ETFs
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is held by 16 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Schwab Emerging Markets Equity ETF (SCHE) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.'s market cap?
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.'s market capitalization is CNY 16.08B.
What is CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.'s P/E ratio?
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.'s price-to-earnings (P/E) ratio is 10.3.
Does CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. pay a dividend?
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. has a dividend yield of 2.5%.
What does CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. do?
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.